Most GLP-1 bills go up the month the medication works. Audit yours.
Dose-tier programs raise the rate every time the dose climbs, which means progress arrives with an invoice. Two taps, and the next 12 months of that math is sitting in front of you in dollars. No body questions. No email.
The month-six math
Month six is when dose-tier bills peak. The starting dose has stepped up twice because the medication is doing its job, and in most programs every step raised the rate: the $225 became $299, then $349. That is the month most people quietly quit, and it is rarely the medication's fault. Some people call it the success tax.
The audit above just priced it for your starting point. RxPros removes the mechanism instead of discounting it: compounded semaglutide starting at $89.97/mo, tirzepatide starting at $119.97/mo, flat for the entire plan at every dose. The dose can move. The number cannot.
Why the math is even possible
Who this is NOT for
- Anyone under 18, or who is pregnant or nursing.
- People who specifically want brand-name injection pens. RxPros dispenses compounded medication in vials.
- Anyone hoping to skip the medical evaluation. There isn't a version of this without one: licensed US providers review every visit, and prescriptions go only to patients who qualify.
Honest gate, honestly stated. The free visit is exactly that: an evaluation, not a checkout.